Total Payments
$3,575
2024 Payments
$1,320
Companies
9
Transactions
20
Medicare Patients
3,429
Medicare Billing
$474,940
Payment Breakdown by Category
Food & Beverage$1,330 (37.2%)
Travel$1,244 (34.8%)
Consulting$1,000 (28.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,330 | 15 | 37.2% |
| Travel and Lodging | $1,244 | 4 | 34.8% |
| Consulting Fee | $1,000 | 1 | 28.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alcon Laboratories Inc | $1,494 | 6 | $0 (2017) |
| Amgen Inc. | $1,320 | 4 | $0 (2024) |
| Johnson & Johnson Surgical Vision, Inc. | $227.68 | 3 | $0 (2018) |
| Alcon Vision LLC | $130.24 | 1 | $0 (2022) |
| Horizon Therapeutics plc | $126.69 | 1 | $0 (2023) |
| Galderma Laboratories, L.P. | $107.64 | 1 | $0 (2019) |
| Omeros Corporation | $98.51 | 1 | $0 (2017) |
| Cook Incorporated | $44.54 | 2 | $0 (2017) |
| Glaukos Corporation | $24.92 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,320 | 4 | Amgen Inc. ($1,320) |
| 2023 | $126.69 | 1 | Horizon Therapeutics plc ($126.69) |
| 2022 | $130.24 | 1 | Alcon Vision LLC ($130.24) |
| 2019 | $107.64 | 1 | Galderma Laboratories, L.P. ($107.64) |
| 2018 | $12.74 | 1 | Johnson & Johnson Surgical Vision, Inc. ($12.74) |
| 2017 | $1,877 | 12 | Alcon Laboratories Inc ($1,494) |
All Payment Transactions
20 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/23/2024 | Amgen Inc. | TEPEZZA (Biological) | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| Category: Inflammation/Rare Disease | ||||||
| 10/01/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $139.57 | General |
| Category: Inflammation/Rare Disease | ||||||
| 10/01/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $32.54 | General |
| Category: Inflammation/Rare Disease | ||||||
| 03/06/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $147.87 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/07/2023 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $126.69 | General |
| Category: TEPEZZA | ||||||
| 07/14/2022 | Alcon Vision LLC | ARGOS (Device) | Food and Beverage | In-kind items and services | $130.24 | General |
| Category: Ophthalmology | ||||||
| 11/02/2019 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $107.64 | General |
| 06/26/2018 | Johnson & Johnson Surgical Vision, Inc. | Tecnis Multifocal Family of 1-piece IOLS (Device) | Food and Beverage | In-kind items and services | $12.74 | General |
| Category: Optics | ||||||
| 08/19/2017 | Alcon Laboratories Inc | ORA (Device) | Travel and Lodging | Cash or cash equivalent | $293.21 | General |
| Category: Ophthalmology | ||||||
| 08/19/2017 | Alcon Laboratories Inc | ORA (Device) | Travel and Lodging | Cash or cash equivalent | $282.72 | General |
| Category: Ophthalmology | ||||||
| 08/19/2017 | Alcon Laboratories Inc | ORA (Device) | Food and Beverage | In-kind items and services | $133.94 | General |
| Category: Ophthalmology | ||||||
| 08/16/2017 | Cook Incorporated | Cook Medical SIS (Device) | Food and Beverage | Cash or cash equivalent | $14.93 | General |
| Category: Surgery | ||||||
| 06/24/2017 | Johnson & Johnson Surgical Vision, Inc. | Tecnis 1-piece IOL (Device), Tecnis Multifocal family of 1-piece IOLs, Tecnis Toric 1-piece IOL | Food and Beverage | In-kind items and services | $90.91 | General |
| Category: Optics | ||||||
| 06/13/2017 | Johnson & Johnson Surgical Vision, Inc. | Tecnis 1-piece IOL (Device), Tecnis Multifocal family of 1-piece IOLs, Tecnis Toric 1-piece IOL | Food and Beverage | In-kind items and services | $124.03 | General |
| Category: Optics | ||||||
| 04/11/2017 | Glaukos Corporation | ISTENT TRABECULAR MICRO-BYPASS STENT SYSTEM (Device) | Food and Beverage | In-kind items and services | $24.92 | General |
| Category: Glaucoma | ||||||
| 02/24/2017 | Alcon Laboratories Inc | AcrySof (Device) | Travel and Lodging | Cash or cash equivalent | $341.91 | General |
| Category: Ophthalmology | ||||||
| 02/24/2017 | Alcon Laboratories Inc | AcrySof (Device), ORA | Travel and Lodging | Cash or cash equivalent | $326.57 | General |
| Category: Ophthalmology | ||||||
| 02/24/2017 | Alcon Laboratories Inc | AcrySof (Device), ORA | Food and Beverage | In-kind items and services | $116.01 | General |
| Category: Ophthalmology | ||||||
| 02/06/2017 | Cook Incorporated | Cook Medical SIS (Device) | Food and Beverage | Cash or cash equivalent | $29.61 | General |
| Category: Surgery | ||||||
| 02/02/2017 | Omeros Corporation | OMIDRIA (Drug) | Food and Beverage | Cash or cash equivalent | $98.51 | General |
| Category: Ophthalmology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 490 | 563 | $368,430 | $57,483 |
| 2022 | 15 | 491 | 3,492 | $316,781 | $57,482 |
| 2021 | 26 | 1,222 | 10,072 | $1.0M | $188,618 |
| 2020 | 24 | 1,226 | 9,295 | $1.0M | $171,358 |
Total Patients
3,429
Total Services
23,422
Medicare Billing
$474,940
Procedure Codes
91
All Medicare Procedures & Services
91 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 66982 | Complex removal of cataract with insertion of prosthetic lens | Facility | 2023 | 20 | 20 | $89,180 | $11,210 | 12.6% |
| 66984 | Removal of cataract with insertion of prosthetic lens | Facility | 2023 | 22 | 27 | $74,763 | $11,017 | 14.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 81 | 95 | $32,680 | $8,907 | 27.3% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 74 | 90 | $24,210 | $5,938 | 24.5% |
| 64612 | Injection of chemical for paralysis of nerve muscles on side of face | Office | 2023 | 12 | 25 | $32,242 | $3,894 | 12.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 33 | 33 | $17,589 | $3,846 | 21.9% |
| 37609 | Tying or biopsy of artery on side of skull | Office | 2023 | 12 | 12 | $15,740 | $2,981 | 18.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 50 | 58 | $13,456 | $2,570 | 19.1% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 15 | 16 | $6,240 | $1,496 | 24.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 22 | 22 | $7,568 | $1,485 | 19.6% |
| 67028 | Injection of drug into eye | Facility | 2023 | 16 | 19 | $24,486 | $1,262 | 5.2% |
| 92082 | Exam of visual field with intermediate testing | Office | 2023 | 32 | 32 | $8,800 | $1,030 | 11.7% |
| 92285 | Photography of content of eyes | Office | 2023 | 55 | 58 | $9,918 | $850.51 | 8.6% |
| 92134 | Imaging of retina | Facility | 2023 | 29 | 39 | $6,747 | $680.40 | 10.1% |
| 92083 | Exam of visual field with extended testing | Facility | 2023 | 17 | 17 | $4,811 | $315.90 | 6.6% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2022 | 19 | 2,935 | $46,960 | $13,811 | 29.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 105 | 120 | $41,280 | $10,462 | 25.3% |
| 66984 | Removal of cataract with insertion of prosthetic lens | Facility | 2022 | 24 | 25 | $69,225 | $10,108 | 14.6% |
| 64612 | Injection of chemical for paralysis of nerve muscles on side of face | Office | 2022 | 26 | 39 | $50,078 | $5,768 | 11.5% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 72 | 82 | $22,058 | $4,406 | 20.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 19 | 19 | $10,127 | $2,337 | 23.1% |
| 67840 | Removal of growth of eyelid | Office | 2022 | 11 | 11 | $12,900 | $2,124 | 16.5% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 24 | 24 | $9,360 | $1,865 | 19.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 21 | 24 | $8,256 | $1,631 | 19.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 38 | 39 | $9,048 | $1,563 | 17.3% |
About Dr. Kamel Itani, MD
Dr. Kamel Itani, MD is a Ophthalmology healthcare provider based in Dallas, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/21/2006. The National Provider Identifier (NPI) number assigned to this provider is 1376509257.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kamel Itani, MD has received a total of $3,575 in payments from pharmaceutical and medical device companies, with $1,320 received in 2024. These payments were reported across 20 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($1,330).
As a Medicare-enrolled provider, Itani has provided services to 3,429 Medicare beneficiaries, totaling 23,422 services with total Medicare billing of $474,940. Data is available for 4 years (2020–2023), covering 91 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Other Specialties Ophthalmic Plastic and Reconstructive Surgery
- Location Dallas, TX
- Active Since 04/21/2006
- Last Updated 06/05/2017
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1376509257
Products in Payments
- TEPEZZA (Biological) $1,320
- AcrySof (Device) $784.49
- ORA (Device) $709.87
- Tecnis 1-piece IOL (Device) $214.94
- ARGOS (Device) $130.24
- TEPEZZA (Drug) $126.69
- OMIDRIA (Drug) $98.51
- Cook Medical SIS (Device) $44.54
- ISTENT TRABECULAR MICRO-BYPASS STENT SYSTEM (Device) $24.92
- Tecnis Multifocal Family of 1-piece IOLS (Device) $12.74
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Dallas
Dr. Oluwatosin Smith, M.d, M.D
Ophthalmology — Payments: $1.5M
Ophthalmology $1.5M
Davinder Grover, M.d, Mph, M.D, MPH
Ophthalmology — Payments: $1.0M
Ophthalmology $1.0M
Dr. Ashkan Abbey, M.d, M.D
Ophthalmology — Payments: $624,167
Ophthalmology $624,167
Dr. Karl Csaky, Md, MD
Ophthalmology — Payments: $583,703
Ophthalmology $583,703
Jeffrey Whitman, M.d, M.D
Ophthalmology — Payments: $272,915
Ophthalmology $272,915
Robert Wang, M.d, M.D
Ophthalmology — Payments: $187,984
Ophthalmology $187,984